Oculisti SISO, ‘riduzioni nei rimborsi e problemi normativi’
Risultati per: Gestire la colica renale nel setting delle cure primarie
Questo è quello che abbiamo trovato per te
Cure agli occhi più efficaci ma pesano liste d'attese e tagli
Oculisti SISO, ‘riduzioni nei rimborsi e problemi normativi’
Implementing Telestroke in the Inpatient Setting: Identifying Factors for Success
Stroke, Ahead of Print. BACKGROUND:Inpatient telestroke programs have emerged as a solution to provide timely stroke care in underserved areas, but their successful implementation and factors influencing their effectiveness remain underexplored. This study aimed to qualitatively evaluate the perspectives of inpatient clinicians located at spoke hospitals participating in a newly established inpatient telestroke program to identify implementation barriers and facilitators.METHODS:This was a formative evaluation relying on semistructured qualitative interviews with 16 inpatient providers (physicians and nurse practitioners) at 5 spoke sites of a hub-and-spoke inpatient telestroke program. The Integrated-Promoting Action on Research Implementation in Health Services framework guided data analysis, focusing on the innovation, recipients, context, and facilitation aspects of implementation. Interviews were transcribed and coded using thematic analysis.RESULTS:Fifteen themes were identified in the data and mapped to the Integrated-Promoting Action on Research Implementation in Health Services framework. Themes related to the innovation (the telestroke program) included easy access to stroke specialists, the benefits of limiting patient transfers, concerns about duplicating tests, and challenges of timing inpatient telestroke visits and notes to align with discharge workflow. Themes pertaining to recipients (care team members and patients) were communication gaps between teams, concern about the supervision of inpatient telestroke advanced practice providers and challenges with nurse empowerment. With regard to the context (hospital and system factors), providers highlighted familiarity with telehealth technologies as a facilitator to implementing inpatient telestroke, yet highlighted resource limitations in smaller facilities. Facilitation (program implementation) was recognized as crucial for education, standardization, and buy-in.CONCLUSIONS:Understanding barriers and facilitators to implementation is crucial to determining where programmatic changes may need to be made to ensure the success and sustainment of inpatient telestroke services.
Tumori, raddoppiati malati che rispondono a cure sperimentali
In studi fase 1. A Roma ricercatori dal mondo per nuove ricerche
Torna Race for the Cure, celebra 25 anni con Mattarella
Corsa dedicata a tumori al seno, investiti negli anni 26 milioni
L'età discrimina, 4 anziani su dieci esclusi dalle cure migliori
L’allarme dei geriatri. Prima Carta al mondo contro l’ageismo
Cure Ssn per italiani all'estero, Giordano nel team per il testo
Il contributo dell’esperto presidente della Sbarro University
Nuove cure garantite da aprile, verso il rinvio per le tariffe
90 associazioni di pazienti a Schillaci, “attesa inaccettabile”
Da sole a volte non basta, i rischi dalle cure per la menopausa fai da te
Per gli esperti del Gemelli la terapia va personalizzata
Tumore alla prostata, passi avanti nelle cure di prima linea
Aifa approva darolutamide nella forma metastatica ormonosensibile
A Padova centro regionale veneto per le cure del Long Covid
Utilizzerà la teleriabilitazione e l’auto-monitoraggio
A Padova centro regionale veneto per le cure del Long Covid
Utilizzerà la teleriabilitazione e l’auto-monitoraggio
REKOVER study protocol: a pRospective patient treatment rEgistry of tramadol and dexKetoprofen trometamol oral fixed-dose combination (SKUDEXA) in mOderate to seVere acutE pain in Real-world setting in Asia
Introduction
Satisfactory management of acute pain remains a major medical challenge despite the availability of multiple therapeutic options including the fixed-dose combination (FDC) drugs. Tramadol and dexketoprofen trometamol (TRAM/DKP) 75/25 mg FDC was launched in 2018 in Asia and is widely used in the management of moderate to severe acute pain. There are limited data on its effectiveness and safety in Asian patients, and therefore, a need to better understand its usage patterns in clinical practice. We aim to understand the usage pattern of TRAM/DKP FDC, its effectiveness and tolerability in patients with moderate to severe acute pain in Asia.
Methods and analysis
REKOVER is a phase-IV, multicountry, multicentre, prospective, real-world observational study. A total of 750 postsurgical and non-surgical patients (male and female, aged 18–80 years) will be recruited from 13 tertiary-care hospitals (15 sites) in Singapore, Thailand, the Philippines and Malaysia. All patients prescribed with TRAM/DKP FDC and willing to participate in the study will be enrolled. The recruitment duration for each site will be 6 months. The severity of pain will be collected using Numeric Pain Rating Scale through the treatment period from day 1 to day 5, while satisfaction with the treatment will be evaluated using Patient Global Evaluation Scale at the end of treatment. Any adverse event reported during the study duration will be recorded for safety analysis (up to day 6). The study data will be entered into the ClaimIt portal and mobile application (app) (ObvioHealth, USA). All the inpatient data will be entered into the portal by the study site and for outpatient it will be done by patients through an app.
Ethics and dissemination
The study has been approved by the local ethics committee from each study sites in Singapore, Thailand, the Philippines and Malaysia. Findings will be disseminated through local and global conference presentations, publications in peer-reviewed scientific journals and continuing medical education.
Cardiomiopatie per 350mila italiani, roadmap per cure migliori
Presentato il primo report, costano a Ssn 650 milioni l’anno
Identifying the top 10 research priorities for the school food system in the UK: a priority setting exercise
Introduction
The school food system varies widely between schools and across the UK. There is a need to understand evidence gaps in school food research to allow the development, implementation and evaluation of policies and interventions to support children’s healthy eating at school. This study aimed to conduct a priority setting exercise to co-produce research priorities in relation to the UK school food system.
Methods
The James Lind Alliance process informed this priority setting exercise; all key steps engaged a wide range of UK school food stakeholders (including teachers, parents, principals, school governors, policymakers, caterers). An initial online stakeholder survey identified perceived research priorities. In a second survey, stakeholders were asked to rank these priorities. Lastly, an online priority setting workshop with stakeholders elicited the most important research priorities.
Results
In 2021, school food stakeholders (n=1280) completed the first survey, from which 136 research priorities were identified. In the second survey, participants (n=107) ranked these research priorities regarding their importance. Lastly, 30 workshop participants discussed and reached consensus on the research priorities. After final refinement by the research team, 18 priorities resulted, with the top 10 being related to the provision of free school meals (effectiveness of cost-effectiveness of different levels of eligibility, including universal provision), implementation of policy (including improving uptake) and food standards, issues around procurement, leadership, inequalities, social norms, the eating environment, food culture throughout the school setting and healthy eating.
Conclusion
The top 10 research priorities were elicited through a rigorous approach, including a wide range of stakeholders across the UK. These should be considered by policymakers, researchers and others to inform research, evidence-based policy development and, ultimately, improve the UK school food system.